DOAR anticipates future litigation trends in emerging areas of life sciences and builds diverse teams of testifying experts who can best inform and advise our clients. We take a proactive approach to deliver insight from leading experts across the pharmaceutical, healthcare technology, and medical device industries, and we regularly work on bet-the-company litigation.

ICYMI, here are some of our top insights in life sciences from this year.

Expert Q&As

A Surgical Robotics Expert Offers Insights on Innovation Impacting the Medical Device Industry

As robotic systems become more sophisticated and integrated into medical practices, new legal challenges are beginning to arise. We asked an accomplished engineer and DOAR robotics expert to evaluate the healthcare technology sector concerning ongoing trends, impactful innovations, and litigation challenges. Read what he had to say.

A Biotechnology Expert Assesses the Life Sciences Landscape

Major shifts in the life sciences sector accelerate growth that increases both competition and legal challenges. We asked an accomplished academic and DOAR biotechnology expert to evaluate the industry with respect to ongoing trends, impactful innovations, and litigation challenges. Read what she says about the industry’s ongoing developments.

Industry Reports

A National Study of Community Attitudes Toward Pharmaceutical Companies

DOAR Research Center conducted a national study of community attitudes toward pharmaceutical companies and several issues suspected of creating bias. Learn more about their findings.

Hatch-Waxman Spotlight: Senior Judge Richard Andrews

In this report, DOAR provides a comprehensive analysis of Senior Judge Richard Andrews’ activity at the United States District Court for the District of Delaware since his appointment in November 2011. Learn more about our findings.

Case Studies

Cardiovascular Expert Needed for Medical Device Dispute

A global healthcare company sued a medical tech firm for allegedly infringing on its patents for a heart treatment device, sparking a legal battle over patent validity and protection. The defendant turned to DOAR for an expert in cardiothoracic surgery and implantable cardiac devices. Read the case study.

Pharmaceutical Experts Needed for ANDA Dispute Concerning Cancer Drugs

The defendant approached DOAR to provide two pharmaceutical experts with advanced knowledge in drug composition, albumin-paclitaxel binding, and nanoparticle delivery. Read the case study.

Contact us to learn why top attorneys trust DOAR to provide the best experts for their matters. We have experience working with clients on a wide range of cases, including patent infringement, product liability, regulatory compliance, data privacy, and intellectual property disputes.

Stay Informed
Stay up to date on our latest news and insights.
Subscribe
Read More
celllphone image with blue light leak in top blocking out screen, insinuating social media issues with jurors
Article
Jan 9, 2026
Social Media Research on Prospective Jurors: Navigating Evolving Ethical Boundaries

As technology transforms what is possible in juror research, the gap between available tools and permissible practices continues to widen, particularly with respect to social media.

Read Now
lines of light making forward movement
Article
Dec 12, 2025
Wireless Litigation Trends at a Glance: Case Trends and Top Parties

Using aggregated filing data from the wireless dataset, we provide a data-driven view of where litigation is concentrated, which parties are most active, and how the structure of the wireless market shapes the legal landscape.

Read Now
black and white looking up at building from ground
Article
Dec 9, 2025
Why Jurisdiction Shapes What Testifying Experts Can Say Before and During Trial

State rules can dramatically alter what experts must disclose before trial and what they’re allowed to say during it. Let’s examine the spectrum of these guidelines and how they shift by location.

Read Now
looking up at a ceiling that are illuminated squares
Article
Nov 7, 2025
Know Your Fact-Finder: Not Just for Jury Trials

Research has shown that external variables can influence decision-making even for “objective” fact-finders. 

Read Now
financial ticker showing up and downward growth
Article
Oct 28, 2025
Cryptocurrency Litigation: Case Types, Segments, and Court Trends at a Glance

New data reveals how crypto disputes are playing out in courtrooms nationwide, as the fast-evolving industry faces growing legal accountability.

Read Now
a triangle pattern with dark shadows showing texture
Article
Sep 26, 2025
Key Takeaways from ALJ Johnson Hines’ Fireside Chat for ITCTLA

DOAR Director, Jeffrey Dorfman, recently attended ITCTLA's panel and procedure event and took note of ALJ Johnson Hines’s practical guidance.

Read Now
financial ticker showing upward growth
Article
Sep 24, 2025
Cryptocurrency Litigation: Parent Companies and Industry Segments at a Glance

Our latest deep dive focuses on crypto litigation an parent-company activity in federal district courts in the U.S..

Read Now
white pill dropped in water resulting in bubbles, black background
Article
Aug 18, 2025
Biologics Litigation: Administrative Judges, Key Players, and Patent Patterns at the PTAB

Across 192 biologics PTAB proceedings, a small group of APJs and repeat innovator and biosimilar companies accounts for much of the activity.

Read Now